Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/1999
06/17/1999WO1999029866A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
06/17/1999WO1999029865A2 A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof
06/17/1999WO1999029864A1 Recombinant vaccinia constructs expressing feline il-2, compositions and methods of use thereof
06/17/1999WO1999029863A1 Human interferon-epsilon: a type i interferon
06/17/1999WO1999029862A1 Synferon, a synthetic type i interferon
06/17/1999WO1999029861A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029859A1 Gene associated with neoplastic disease or malignancy associated gene
06/17/1999WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029854A1 Human patched genes and proteins, and uses related thereto
06/17/1999WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999WO1999029852A1 High-affinity tryptophan transporter
06/17/1999WO1999029851A1 Human 'kismet' protein hkis acts as a tumor suppressor
06/17/1999WO1999029850A1 HUMAN KISMET PROTEIN (hkis) ACTS AS AN ONCOGENE
06/17/1999WO1999029849A1 G-protein coupled receptors associated with immune response
06/17/1999WO1999029848A1 Novel vectors and genes exhibiting increased expression
06/17/1999WO1999029847A1 T-type voltage-gated calcium channels and method of using same
06/17/1999WO1999029846A1 Transgenic mice expressing the h/k-ras 4b chimeric gene
06/17/1999WO1999029845A1 SEQUENCES CODING FOR kin17 PROTEIN AND THEIR APPLICATIONS
06/17/1999WO1999029844A2 Novel retroelements zam and idemfix, and their integrase
06/17/1999WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999WO1999029842A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999WO1999029841A1 Purification and microsequencing of hyaluronidase isozymes
06/17/1999WO1999029834A1 Methods for preparation of vaccines against cancer
06/17/1999WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999WO1999029731A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
06/17/1999WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999WO1999029729A2 Antagonists of neuropilin receptor function and use thereof
06/17/1999WO1999029727A1 Cyp7 promoter-binding factors
06/17/1999WO1999029726A1 Phospholipase inhibitor
06/17/1999WO1999029725A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5
06/17/1999WO1999029724A2 Dna encoding pasteurella multocida outer membrane protein
06/17/1999WO1999029723A1 Recombinant nodavirus compositions and methods
06/17/1999WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4
06/17/1999WO1999029721A1 Anti-pathogen system and methods of use thereof
06/17/1999WO1999029720A2 Mammalian alpha helical protein-1
06/17/1999WO1999029719A2 Pancreatic-derived factors, and uses related thereto
06/17/1999WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999WO1999029715A1 Tumor antigen peptide derivatives
06/17/1999WO1999029350A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999WO1999029344A1 Product and process for targeting an immune response
06/17/1999WO1999029341A2 Methods for enhancement of protective immume responses employing leishmania polypeptides
06/17/1999WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999WO1999029334A1 CtIP, A NOVEL PROTEIN THAT INTERACTS WITH CtBP AND USES THEREFOR
06/17/1999WO1999029310A2 Regulation of t cell-mediated immunity by tryptophan and its analogs
06/17/1999WO1999029183A1 A process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
06/17/1999WO1999029182A1 Method for purifying heat shock peptides complexes
06/17/1999WO1999029159A1 Plant senescence-associated genes
06/17/1999WO1999018230A3 Method to detect mrit and bcl-2 or caspase association alterations
06/17/1999WO1999018216A3 Chimeric vaccine against tick-borne encephalitis virus
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999016883A3 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN
06/17/1999WO1999015554A3 Ras-like protein
06/17/1999WO1999015548A3 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
06/17/1999WO1999015009A9 TRYPSIN INHIBITORS WITH INSECTICIDAL PROPERTIES OBTAINED FROM $i(PENTACLETHRA MACROLOBA)
06/17/1999WO1999011783A3 T-box polypeptides
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1999007739A8 Dna encoding the human synapsin iii gene and uses thereof
06/17/1999WO1999004237A3 Diagnosis of spongiform encephalopathies using prionins
06/17/1999WO1998056919A3 Methods and reagents for vaccination which generate a cd8 t cell immune response
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/17/1999DE19755302A1 Neuer Transkriptionsfaktor CPCR1 zur Regulation des Isopenicillin N-Synthetase-Gens (pcbC) und des AC-/ACV-Synthetase-Gens (pcbAB) CPCR1 new transcription factor in the regulation of the isopenicillin N synthetase gene (pcbC) and the AC / ACV synthetase gene (pcbAB)
06/17/1999DE19754774A1 Transgenes nicht-menschliches Säugetier mit einer onkogenen Mutante des Raf-1-Gens A transgenic non-human mammal with an oncogenic mutant of the Raf-1 gene
06/17/1999CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
06/17/1999CA2318476A1 Plant senescence-associated genes
06/17/1999CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same
06/17/1999CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4
06/17/1999CA2315216A1 Tgc method for inducting targeted somatic transgenesis
06/17/1999CA2314434A1 Dna molecules encoding human nuclear receptor protein, nnr5
06/17/1999CA2314267A1 Anti-pathogen system and methods of use thereof
06/17/1999CA2314005A1 Methods for preparation of vaccines against cancer
06/17/1999CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides
06/17/1999CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313607A1 Antagonists of neuropilin receptor function and use thereof
06/17/1999CA2313483A1 Assessment of human papilloma virus-related disease
06/17/1999CA2313464A1 Mammalian alpha helical protein-1
06/17/1999CA2313450A1 G-protein coupled receptors associated with immune response
06/17/1999CA2313447A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof
06/17/1999CA2313390A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof
06/17/1999CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna
06/17/1999CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/17/1999CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto
06/17/1999CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
06/17/1999CA2312477A1 T-type voltage-gated calcium channels and method of using same
06/17/1999CA2312291A1 Novel vectors and genes exhibiting increased expression
06/17/1999CA2312289A1 Tumor antigen peptide derivatives
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2312273A1 Cancer susceptibility mutations of brca1
06/17/1999CA2312049A1 Method for purifying heat shock peptides complexes
06/17/1999CA2312006A1 Nucleic acid mediated rna tagging and rna revision
06/17/1999CA2311681A1 Human interferon-epsilon: a type i interferon
06/17/1999CA2311645A1 Gene family with transformation modulating activity
06/17/1999CA2311283A1 Purification and microsequencing of hyaluronidase isozymes
1 ... 2274 2275 2276 2277 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 ... 2916